Icon releases Flex Advantage to support adaptive trial design

By Melissa Fassbender contact

- Last updated on GMT

Image: iStock
Image: iStock
ICON has announced Flex Advantage, its next-generation Interactive Response Technology (IRT) platform, as sponsors and investigators continue to embrace adaptive trial designs.

In response to our client’s needs, we have updated our IRT platform to be more efficient by utilizing a modular system architecture with reusable functionality​,” Dr. Malcolm Burgess, Executive VP, Interactive Technologies, ICON, told Outsourcing-Pharma.com.

The new platform offers enhanced randomization and clinical supply management capabilities to support adaptive trial execution – a practice which, according to Tufts​, can save companies millions each year.

These changes allow for faster implementation coupled with increased quality,​” added Burgess.

 “The updates were completed in order to upgrade our technology base and to give us a database structure that would allow us to seamlessly integrate with other technologies in the clinical supply ecosystem. This includes linkages to statistical applications to enable adaptive trial support​.”

Adaptive trial designs

The main benefit of the new platform is its flexible randomization engine that can be adjusted mid study. For example, treatment arms can be added or removed as appropriate after an interim analysis.

According to Burgess, this enables adaptive clinical studies while protecting the blind and maintaining data integrity, which has been a major concern for adaptive trial adoption in the past.

Unblinded statisticians can log in and review or even download patient data, the interface then allows them to adjust the randomization design if appropriate​,” he added.

Additionally, the company has developed what it calls the Adaptive Execution Environment, which allows execution of interim and final analyses in a controlled environment with full action traceability.

All programs needed for an interim analysis are prepared by statisticians or statistical programmers in advance and can be invoked via the web interface of the Adaptive Execution Environment as appropriate during the course of the trial​,” explained Burgess.

This allows users to review results, log files, and audit information of all interim analyses at any time. It also eliminates manual data hand-overs for data consistency and reduces the time needed for the analysis.

Analysis results are then available to authorized team members either for on-line review or download before a decision is made and the changes implemented via the Adaptive Execution Environment.

Related news

Show more

Related products

show more

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Empowering Clinical Trial Sponsors with Analytics

Empowering Clinical Trial Sponsors with Analytics

PerkinElmer | 14-Jul-2021 | Technical / White Paper

Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...

Related suppliers

Follow us

Products

View more

Webinars